Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Ciliary Genes Are Down-Regulated in Bronchial Tissue of Primary Ciliary Dyskinesia Patients

  • Maciej Geremek ,

    Affiliations: International Institute of Molecular and Cell Biology, Warsaw, Poland, Genetics Department, University Medical Centre Groningen and University of Groningen, Groningen, the Netherlands, Complex Genetics Group, Department of Biomedical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands

  • Ewa Ziętkiewicz,

    Affiliation: Department of Molecular and Clinical Genetics, Institute of Human Genetics, Poznan, Poland

  • Marcel Bruinenberg,

    Affiliation: Genetics Department, University Medical Centre Groningen and University of Groningen, Groningen, the Netherlands

  • Lude Franke,

    Affiliation: Genetics Department, University Medical Centre Groningen and University of Groningen, Groningen, the Netherlands

  • Andrzej Pogorzelski,

    Affiliation: Institute of Tuberculosis and Lung Diseases, Rabka, Poland

  • Cisca Wijmenga ,

    Contributed equally to this work with: Cisca Wijmenga, Michał Witt

    Affiliations: Genetics Department, University Medical Centre Groningen and University of Groningen, Groningen, the Netherlands, Complex Genetics Group, Department of Biomedical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands

  • Michał Witt

    Contributed equally to this work with: Cisca Wijmenga, Michał Witt

    Affiliations: International Institute of Molecular and Cell Biology, Warsaw, Poland, Department of Molecular and Clinical Genetics, Institute of Human Genetics, Poznan, Poland

Ciliary Genes Are Down-Regulated in Bronchial Tissue of Primary Ciliary Dyskinesia Patients

  • Maciej Geremek, 
  • Ewa Ziętkiewicz, 
  • Marcel Bruinenberg, 
  • Lude Franke, 
  • Andrzej Pogorzelski, 
  • Cisca Wijmenga, 
  • Michał Witt
  • Published: February 6, 2014
  • DOI: 10.1371/journal.pone.0088216


Primary ciliary dyskinesia (PCD) is a rare, genetically heterogeneous disease characterized by recurrent respiratory tract infections, sinusitis, bronchiectasis and male infertility. The pulmonary phenotype in PCD is caused by the impaired motility of cilia in the respiratory epithelium, due to ultrastructural defects of these organelles. We hypothesized that defects of multi-protein ciliary complexes should be reflected by gene expression changes in the respiratory epithelium. We have previously found that large group of genes functionally related to cilia share highly correlated expression pattern in PCD bronchial tissue. Here we performed an explorative analysis of differential gene expression in the bronchial tissue from six PCD patients and nine non-PCD controls, using Illumina HumanRef-12 Whole Genome BeadChips. We observed 1323 genes with at least 2-fold difference in the mean expression level between the two groups (t-test p-value <0.05). Annotation analysis showed that the genes down-regulated in PCD biopsies (602) were significantly enriched for terms related to cilia, whereas the up-regulated genes (721) were significantly enriched for terms related to cell cycle and mitosis. We assembled a list of human genes predicted to encode ciliary proteins, components of outer dynein arms, inner dynein arms, radial spokes, and intraflagellar transport proteins. A significant down-regulation of the expression of genes from all the four groups was observed in PCD, compared to non-PCD biopsies. Our data suggest that a coordinated down-regulation of the ciliome genes plays an important role in the molecular pathomechanism of PCD.


Cilia are small cellular projectiles, extending from the cell surface, with which they share the cell membrane. The ciliary axoneme is built on a scaffold of nine peripheral microtubule doublets, associated with many multi-protein complexes, including outer and inner dynein arms (ODA and IDA), nexin links and radial spokes. Cilia act either as sensors (primary cilia) or propel fluid over the epithelia of various organs (motile cilia) [1]; their dysfunction is the underlying cause of many systemic diseases.

Primary ciliary dyskinesia (PCD) is a rare genetic disease characterized by recurrent respiratory tract infections, bronchiectasis and infertility. Pulmonary symptoms occur because of the lack of an efficient mucociliary clearance, caused by the kinetic dysfunction of motile cilia in the respiratory epithelium. Male infertility is caused by the dysmotility of flagella in spermatozoids. Situs inversus, a mirror reversal of body organ positioning, is present in approximately half of the PCD patients because of the immotility of primary cilia of the embryonic node [2], [3]. In rare cases, PCD symptoms are a part of syndromic diseases, e.g. X-linked retinitis pigmentosa [4], [5] and oral-facial-digital type I syndrome [6]. The diagnosis of PCD is based on the clinical criteria, the delayed saccharin test [7], and low levels of nasal nitric oxide [8]. These symptoms are supported by the imaging studies of the respiratory cilia. Tissue specimens obtained through bronchoscopy are evaluated in the light microscope for ciliary beating and with the electron microscope for defects of the ciliary ultrastructure. Among a wide spectrum of various ultrastructural ciliary lesions documented in PCD patients [9], the lack of ODA and/or IDA is the most frequently observed defect.

Genetically, PCD is a largely autosomal recessive trait with extensive heterogeneity. To date, nineteen genes have been found to be mutated in PCD: DNAH5 [10], DNAH11 [11], DNAI1 [12], DNAI2 [13], RSPH9 [14], RSPH4A [14], TXNDC3 [15], KTU/PF13 [16], LRRC50 [17], [18], CCDC39 [19], CCDC40 [20], CCDC103 [21], HEATR2 [22], LRRC6 [23], DNAL1[24], DNAAF3 [25], HYDIN [26], CCDC114 [27],CCDC164 [28], CCDC65 [29], c21orf59 [30], SPAG1 [31], ZMYND10 [32], RSPH1 [33], ARMC4 [34], and DYX1C1/DNAAF4 [35]; additional genes are involved in syndromic forms of PCD: RPGR [4], [5] and OFD1 [6]. Products of most of the PCD-related genes have conserved orthologs in Chlamydomonas reinhardtii and have a well-defined ultrastructural localization in the axoneme. However, the large complexity of the cilium, which is composed of hundreds of proteins, renders studying the ciliary function a difficult task. In effect, the genetic basis of PCD in about half of patients remains unknown.

Previously, in search for a better understanding of the molecular basis of functional defects of cilia in PCD, we have performed the whole-genome expression profiling in bronchial biopsies from six PCD patients [36]. Clustering analysis revealed a large group of genes with highly correlated expression pattern in PCD biopsies, but not in controls; based on the series of in silico analyses, we have indicated over 200 new genes potentially involved in the biology of human cilia. In the present study, we further explored the gene expression profiling data to characterize patterns of differential gene expression in bronchial tissue from PCD patients and non-PCD controls. We report that the significant proportion of genes that are down-regulated in PCD encode specific elements of the cilium, suggesting that a coordinated down-regulation of the ciliome genes plays an important role in the molecular pathomechanism of PCD.

Materials and Methods

Ethics statement

The Institutional Review Board (IRB) of the Medical University of Poznań approved use of bronchial biopsy specimens of patients and controls for genetic studies on PCD. Specimens were collected during routine hospital procedures. Written informed consent was obtained from all subjects.

Bronchial biopsies and subjects

Material for this study, obtained from six unrelated PCD patients and nine unrelated control individuals, has been described in detail in Geremek et al. [36]. Briefly, clinical evaluation of the PCD patients was performed at the Institute of Tuberculosis and Lung Diseases in Rabka, Poland, by the experienced physician (AP). The primary bronchopulmonary symptoms in the patients were: sinusitis, nasal polyps, bronchiectasis, and recurrent infections of the upper respiratory tract. PCD status was also indicated by the positive results of routine diagnostic tests: the delayed saccharine test and lack of the ciliary motility in light microscopy imaging. In four patients (#1, 2, 3, 4), PCD diagnosis was confirmed by the low level of NO (25–188 ppb), measured in the nasal cavity (chemiluminescence analyzer, the threshold value of 200 ppb) [8] (Table S1). Three of these patients (#1, 3, 4) had ODA/IDA defect. One patient (#6) for whom no NO data were available had IDA defect and another one (#5) in whom NO level was in the normal range had ODA/IDA defect. Two of the patients (#5, 6) had situs inversus. The mutational status was known for one patient (patient #4), who was a compound heterozygote for two mutations in DNAH5. Non-PCD controls were individuals referred to the Institute of Tuberculosis and Lung Diseases in Rabka for various reasons unrelated to PCD; they presented no symptoms of acute pulmonary disease, no bronchoscopic signs of the disturbance of mucociliary transport, and had normal ciliary beating in the light microscopy.

Biopsies were obtained during a diagnostic bronchoscopy, using the same protocol in PCD and non-PCD individuals. Specimens were stored in RNAlater buffer and used for RNA isolation.

Gene expression analysis

The quality and concentration of RNA were determined using the 2100 Bioanalyzer (Agilent, Amstelveen, The Netherlands) with the Agilent RNA 6000 Nano Kit. Anti-sense RNA was synthesized, amplified and purified using the Ambion Illumina TotalPrep Amplification Kit (Ambion, USA) according to the manufacturer's protocol. Complementary RNA was hybridized to Illumina HumanRef-12 Whole Genome BeadChips and scanned on the Illumina BeadArray Reader. Data was handled through the Illumina BeadStudio Gene Expression module v3.2. The expression data has been submitted to GEO under accession number GSE25186.


Initial steps of data preprocessing, quantile normalization, background subtraction and quality control were performed using the BeadStudio software. The data were exported to GeneSpring 9. Expression values with a threshold value below 5 were raised to 5, and the data were scaled by a base 2 logarithm.

Ensembl Biomart module was used to obtain Ensemble gene IDs of the differentially expressed genes that were subject to annotation enrichment analysis and the Ciliome database ( [37] search. Fold-change analysis for all the probes was performed using GeneSpring 9 software. Genes that had at least 2-fold expression change (with the t-test p-value <0.05) in PCD patients as compared to the controls were subjected to gene annotation enrichment analysis using DAVID (Database for Annotation, Visualization, and Integrated Discovery) [38]. DAVID applies a modified Fisher exact test, to establish if the proportion of genes falling into an annotation category differs for a particular group of genes and the background group of genes; the p-values were corrected for multiple testing using the FDR method. The resulting annotation terms were then clustered into functional groups.

PubMed was used as references for known ciliary genes encoding components of radial spokes and intraflagellar transport proteins. Outer and inner dynein arms genes were taken from Pazour et al [39]. The R package was used for statistical calculations.

The log2-transformed mean expression values for the probes representing protein components of the specific ultrastructural ciliary elements were compared in the patients and controls, and the Wilcoxon Mann-Whitney test was used to obtain p-values for individual comparisons. In case of genes represented by multiple probes, mean values were used for calculations. The unweighted Z-method of combining probabilities from independent tests was used to assess if the distribution of p-values deviated from normal [40]. The Z-transform test converts one-tailed p-values from each of the independent tests into standard normal deviates; the sum of these standard normal deviates, divided by the square root of the number of tests, has a standard normal distribution if the common null hypothesis is true.


Whole genome analysis (fold change and gene enrichment)

We identified 1323 genes (1396 probes), which displayed at least 2-fold difference in the expression level in PCD compared to non-PCD bronchial tissue (t-test p-value <0.05); 721of these genes (755 probes) were over-expressed, whereas 602 genes (641 probes) showed a reduced expression in PCD (Table S2).

To investigate the biological meaning of these differentially expressed genes, we performed annotation enrichment analysis, separately for the up-regulated and down-regulated genes, using DAVID software [38]. Annotations of the genes with the reduced expression in PCD patients were significantly enriched for terms related to microtubules, motility, cilia, and dyneins (Table 1). In the group of up-regulated genes, the highest scoring cluster was related to cell cycle and mitosis (Table 2). To investigate how many of the down- and up-regulated genes were functionally linked to cilia, the two groups (genes from Table S2) were used to query the Ciliome database [37]. This search revealed that 19% of the down-regulated and 11% of the up-regulated genes were related to cilia. Under a theoretical assumption that approximately 10% of the human genes are related to cilia (the Ciliome database contains 2024 entries), the proportion of ciliary genes found in the down-regulated group was significantly higher than in the whole set of human genes (binominal p-value 1.69e-08), while the list of up-regulated genes was not significantly enriched for genes related to cilia (p-value 0.26).

Table 1. Gene annotation analysis of the genes down-regulated in PCD (fold change >2.0, and p<0.05).


Table 2. Gene annotation analysis of the genes up-regulated in PCD (fold change >2 and p<0.05).


Known ciliary genes

To search for the evidence of differential expression of the genes related to specific elements of the axonemal ultrastructure, we assembled a list of human proteins represented on the microarray and predicted to be a part of the known ultrastructural ciliary components (ODA, IDA, radial spokes, intraflagellar transport-related proteins). We used the data from Pazour et al. [39], who applied phylogenetic analysis to assign human heavy dynein chains to ultrastructural components of outer and dyneins arms of flagella, and from Hom et al. [41], who compiled data on the nomenclature of dyneins. The assignment of the remaining genes was based on the PubMed search.

The resulting list of 37 human genes encoding proteins predicted to be a part of known ciliary components included: 8 ODA genes, 10 IDA genes, 8 radial spoke genes and 11 intraflagellar transport genes (Table 3). The log 2-transformed mean expression levels in PCD and non-PCD bronchial tissues, the fold change, the log2 of the fold change and the corresponding Wilcoxon Mann-Whitney test p-values are presented in Table 3. All the genes had a lower expression in PCD than in controls. Statistically significant evidence of the down-regulation in PCD was also observed when the combined p-values were calculated, using an unweighted Z-method [33], in four subgroups of the genes encoding ciliary components: ODA (p = 3.5e-08), IDA (p = 3.19e-12), radial spokes (p = 1.06e-4) and intraflagellar transport proteins (p = 1.27e-07), respectively (Table 3).

Table 3. Differential expression of the genes encoding outer dynein arms, inner dynein arms, radial spokes and intraflagellar transport proteins in the group of PCD cases compared to the non-PCD controls.


The results were not dependent on individual PCD patients. Removing of each of the PCD subject did not significantly change the result of gene annotation analysis. Evidence of the down-regulation in four subgroups of the genes encoding ciliary components remained also significant.


A combination of the fold change with the significance measured by an uncorrected t-test (which takes into consideration the variance between the samples), has been shown to be a reliable and reproducible measure of differential expression [42].The gene expression profiling using the whole-genome Illumina panel, performed in bronchial biopsies from six PCD patients and nine non-PCD controls, revealed 1396 probes (representing 1323 genes) with at least 2 fold expression level difference between the PCD and non-PCD groups (t-test p-value <0.05). Functional annotation of the differentially expressed genes revealed that those down-regulated in PCD were related to microtubules, motility and cilia, and the up-regulated ones to the cell cycle and mitosis, i.e. to the processes that are related to microtubules by mitotic spindle and centrioles.

To further characterize the expression changes in PCD, we analyzed expression levels of a number of cilia-related genes represented on the chip. We assembled the list of 37 human genes representing: three subgroups, related to the ultrastructural components of motile cilia (outer dynein arms, inner dynein arms, and radial spokes), plus one functional subgroup (intraflagellar transport proteins). In all these subgroups, the reduced expression in bronchial biopsies from PCD patients was observed. The largest number of probes exhibiting significantly decreased expression was observed in the group of genes encoding components of inner and outer dynein arms.

Of the twenty-six genes known to be mutated in PCD, CCDC39, CCDC164 and SPAG1 were not represented on the array and TXNDC3 was not stably expressed. Of the remaining twenty-two stably expressed genes (Table 4), ten were significantly down-regulated (>2-fold change and p<0.05). The majority of the down-regulated PCD genes encoded components of cilia ultrastructure: ODA (DNAH11, DNAH5, DNAI1, DNAI2, DNAL1, CCDC114); central pair appendix (HYDIN). The remaining down-regulated PCD genes encoded cytoplasmic proteins required for the assembling of dynein arms (LRCC50 alias DNAAF1, ZMYND10). In twelve of the PCD genes the expression level did not significantly differ between PCD and non-PCD biopsies; five of these genes (KTU alias DNAAF2, CCDC103, DYX1C1, c21orf59 and C19ORF52 alias DNNAAF3) encoded cytoplasmic assembly proteins, two (CCDC40 and CCDC65) encoded N-DRC (nexin-denein regulatory complex) proteins, one (HEATR2) encoded protein of an unknown location and three encoded radial spokes proteins (RSPH4A, RSPH1 and RSPH9), one (ARMC4) encoded ODA docking component; only the expression of DNAAF3 and CCDC40 was slightly higher in PCD than in healthy controls. ODF1 associated with the syndromic form of PCD, was expressed at the significantly lower lever in PCD patients. DYX1C1, LRCC6, RPGR, RSPH1 had the fold change >2 but the p-values were between 0.05 and 0.1.

Table 4. Differential expression of the genes mutated in PCD and two genes mutated in syndromic disorders associated with PCD symptoms (RPGR and ODF1).


Given the lack of linear relation between RNA and protein, direct conclusions about a possible correlation between the RNA level and ultrastructural ciliary defects cannot be made. Large multi-protein complexes of the dynein arms are pre-assembled in the cytoplasm, before their intraflagellar transport to the ciliary axonemes. Immunohistochemical staining of the ciliated epithelium from PCD patients with identified mutations has shown that a defect/absence of one of the ciliary proteins may impair the delivery or assembly of other, non-mutated members of the axonemal substructures [43]. This relationship has been shown e.g. for mutated DNAH5 or DNAI1 and DNAH9 [43], mutated KTU and components of ODA/IDA [16], mutated CCDC40 or CCDC39 and components of IDA [19], [20], mutated LRRC6 and components of ODA/IDA [23]. Our data suggest that this impairment of the ciliary ultrastructure assembly may in fact originate at the transcription level; we hypothesize that a regulatory system may exist, which – in the presence of a mutated ciliary gene – down-regulates the expression of at least part of the ciliary genome. Such a regulation would play an important role in the molecular pathomechanism of PCD. During ciliogenesis the expression of ciliary genes is regulated by common transcription factors. The FOXJ1 transcription factor and RFX (regulatory factor X) family of transcription factors have been shown to regulate the expression of many cilia related genes. We have found FOXJ1 (FC = 2,086838) and RFX2 (FC = 2,412601) among the down-regulated genes indicating that the putative regulatory event acts upstream of these two transcription factors[44].

In our study, the strongest evidence of a significant down-regulation of the cilia-related genes in PCD bronchial biopsies concerned the genes predicted to encode elements of the inner and outer dynein arms and to a lesser extent, elements of radial spokes and proteins involved in ODA assembly or in the intraflagellar transport. The small study group provides only the proof of the concept and further studies are warranted. For example, to estimate the specificity of a putative regulatory system it will be important to repeat similar analyses using groups of patients carrying mutations in the same gene. In our small group of patients, only one of the patients had a known mutational status (two complementary heterozygous mutations in DNAH5). DNAH5 is the strongest contributor to the genetic background of PCD, but one cannot exclude the possibility that there were mutations in other genes among the patients we examined. One may envision that the homogeneous group of patients with the mutations in the specific genes would cause different groups of the ciliary genes to undergo down-regulation.

Apart from the contribution to the understanding of the mechanisms of ciliary assembly, such studies may contribute to finding further candidate genes in PCD. To date, a number of candidate disease genes in several genomic regions reported to be linked to PCD remain to be identified; the failure of many linkage studies may be ascribed to the noise in linkage data, and difficulties in the functional prioritization of the candidate genes. In this context, observation of a down-regulation of the particular gene's expression in PCD might provide clues for selecting candidate genes from the linkage peaks.

Supporting Information

Table S1.

Electron microscopy, NO measurements and situs status in the PCD patients studied.



Table S2.

Differentially expressed genes (fold change >2 and p<0.05).




The cooperation of all the Polish families who participated in this study was invaluable. We thank Jackie Senior for editing the manuscript and Ewa Rutkiewicz for laboratory assistance. We thank the staff of the Genomics Facility, UMCG, for scientific and technical work. MG was supported by the International PhD Program of the University of Utrecht.

Author Contributions

Conceived and designed the experiments: MG CW MW. Performed the experiments: MG MB. Analyzed the data: MG LF EZ. Contributed reagents/materials/analysis tools: AP. Wrote the paper: MG EZ.


  1. 1. Satir P, Christensen ST (2008) Structure and function of mammalian cilia. Histochem Cell Biol 129: 687–93. doi: 10.1007/s00418-008-0416-9
  2. 2. Marshall WF (2008) The cell biological basis of ciliary disease. J Cell Biol 180: 17–21. doi: 10.1083/jcb.200710085
  3. 3. Geremek M, Witt M (2004) Primary ciliary dyskinesia: genes, candidate genes and chromosomal regions. J Appl Genet 45: 347–61.
  4. 4. Moore A, Escudier E, Roger G, Tamalet A, Pelosse B, et al. (2006) RPGR is mutated in patients with a complex X linked phenotype combining primary ciliary dyskinesia and retinitis pigmentosa. J Med Genet 43: 326–333. doi: 10.1136/jmg.2005.034868
  5. 5. Bukowy-Bieryłło Z, Ziętkiewicz E, Loges NT, Wittmer M, Geremek M, et al. (2012) RPGR mutations might cause reduced orientation of respiratory cilia. Pediatr Pulmonol 48: 352–63. doi: 10.1002/ppul.22632
  6. 6. Budny B, Chen W, Omran H, Fliegauf M, Tzschach A, et al. (2006) A novel X-linked recessive mental retardation syndrome comprising macrocephaly and ciliary dysfunction is allelic to oral-facial-digital type I syndrome. Hum Genet. 120: 171–178. doi: 10.1007/s00439-006-0210-5
  7. 7. Canciani M, Barlocco EG, Mastella G, de Santi MM, Gardi C, et al. (1988) The saccharin method for testing mucociliary function in patients suspected of having primary ciliary dyskinesia. Pediatr Pulmonol 5: 210–4. doi: 10.1002/ppul.1950050406
  8. 8. Karadag B, James AJ, Gultekin E (1999) Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia. Eur Respir J 13: 1402–1405. doi: 10.1183/09031936.99.13614069
  9. 9. Zariwala MA, Knowles MR, Omran H (2007) Genetic defects in ciliary structure and function. Annu Rev Physiol 69: 423–50. doi: 10.1146/annurev.physiol.69.040705.141301
  10. 10. Olbrich H, Häffner K, Kispert A, Völkel A, Volz A, et al. (2002) Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right asymmetry. Nat Genet 30: 143–4. doi: 10.1038/ng817
  11. 11. Bartoloni L, Blouin JL, Pan Y, Gehrig C, Maiti AK, et al. (2002) Mutations in the DNAH11 (axonemal heavy chain dynein type 11) gene cause one form of situs inversus totalis and most likely primary ciliary dyskinesia. Proc Natl Acad Sci 99: 10282–6. doi: 10.1073/pnas.152337699
  12. 12. Pennarun G, Escudier E, Chapelin C, Bridoux AM, Cacheux V, et al. (1999) Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia. Am J Hum Genet 65: 1508–1519. doi: 10.1086/302683
  13. 13. Loges NT, Olbrich H, Fenske L, Mussaffi H, Horvath J, et al. (2008) DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm. Am J Hum Genet 83: 547–558. doi: 10.1016/j.ajhg.2008.10.001
  14. 14. Castleman VH, Romio L, Chodhari R, Hirst RA, de Castro SC, et al. (2009) Mutations in radial spoke head protein genes RSPH9 and RSPH4A cause primary ciliary dyskinesia with central-microtubular-pair abnormalities. Am J Hum Genet 84: 197–209. doi: 10.1016/j.ajhg.2009.01.011
  15. 15. Duriez B, Duquesnoy P, Escudier E, Bridoux AM, Escalier D, et al. (2007) A common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesia. Proc Natl Acad Sci 104: 3336–41. doi: 10.1073/pnas.0611405104
  16. 16. Omran H, Kobayashi D, Olbrich H, Tsukahara T, Loges NT, et al. (2008) Ktu/PF13 is required for cytoplasmic pre-assembly of axonemal dyneins. Nature 456: 611–616. doi: 10.1038/nature07471
  17. 17. Duquesnoy P, Escudier E, Vincensini L, Freshour J, Bridoux AM, et al. (2009) Loss-of-function mutations in the human ortholog of Chlamydomonas reinhardtii ODA7 disrupt dynein arm assembly and cause primary ciliary dyskinesia. Am J Hum Genet 85: 890–896. doi: 10.1016/j.ajhg.2009.11.008
  18. 18. Loges NT, Olbrich H, Becker-Heck A, Häffner K, Heer A, et al. (2009) Deletions and point mutations of LRRC50 cause primary ciliary dyskinesia due to dynein arm defects. Am J Hum Genet 85: 883–889. doi: 10.1016/j.ajhg.2009.10.018
  19. 19. Merveille AC, Davis EE, Becker-Heck A, Legendre M, Amirav I, et al. (2011) CCDC39 is required for assembly of inner dynein arms and the dynein regulatory complex and for normal ciliary motility in humans and dogs. Nat Genet 43: 72–8. doi: 10.1038/ng.726
  20. 20. Becker-Heck A, Zohn IE, Okabe N, Pollock A, Lenhart KB, et al. (2011) The coiled-coil domain containing protein CCDC40 is essential for motile cilia function and left-right axis formation. Nat Genet 43: 79–84. doi: 10.1038/ng.727
  21. 21. Panizzi JR, Becker-Heck A, Castleman VH, Al-Mutairi DA, Liu Y, et al. (2012) CCDC103 mutations cause primary ciliary dyskinesia by disrupting assembly of ciliary dynein arms. Nat Genet 44: 714–9. doi: 10.1038/ng.2277
  22. 22. Horani A, Druley TE, Zariwala MA, Patel AC, Levinson BT, et al. (2012) Whole-exome capture and sequencing identifies HEATR2 mutation as a cause of primary ciliary dyskinesia. Am J Hum Genet 91: 685–93. doi: 10.1016/j.ajhg.2012.08.022
  23. 23. Kott E, Duquesnoy P, Copin B, Legendre M, Dastot-Le Moal F, et al. (2012) Loss-of-function mutations in LRRC6, a gene essential for proper axonemal assembly of inner and outer dynein arms, cause primary ciliary dyskinesia. Am J Hum Genet 91: 958–64. doi: 10.1016/j.ajhg.2012.10.003
  24. 24. Mazor M, Alkrinawi S, Chalifa-Caspi V, Manor E, Sheffield VC, et al. (2011) Primary ciliary dyskinesia caused by homozygous mutation in DNAL1, encoding dynein light chain 1. Am J Hum Genet 88: 599–607. doi: 10.1016/j.ajhg.2011.03.018
  25. 25. Mitchison HM, Schmidts M, Loges NT, Freshour J, Dritsoula A, et al. (2012) Mutations in axonemal dynein assembly factor DNAAF3 cause primary ciliary dyskinesia. Nat Genet 44: 381–9. doi: 10.1038/ng.1106
  26. 26. Olbrich H, Schmidts M, Werner C, Onoufriadis A, Loges NT, et al. (2012) Recessive HYDIN mutations cause primary ciliary dyskinesia without randomization of left-right body asymmetry. Am J Hum Genet 91: 672–84. doi: 10.1016/j.ajhg.2012.08.016
  27. 27. Onoufriadis A, Paff T, Antony D, Shoemark A, Micha D, et al. (2013) Splice-Site Mutations in the Axonemal Outer Dynein Arm Docking Complex Gene CCDC114 Cause Primary Ciliary Dyskinesia. Am J Hum Genet 92: 88–98. doi: 10.1016/j.ajhg.2012.11.002
  28. 28. Wirschell M, Olbrich H, Werner C, Tritschler D, Bower R, et al. (2013) The nexin-dynein regulatory complex subunit DRC1 is essential for motile cilia function in algae and humans. Nat Genet 45: 262–8. doi: 10.1038/ng.2533
  29. 29. Horani A, Brody SL, Ferkol TW, Shoseyov D, Wasserman MG, et al. (2013) CCDC65 mutation causes primary ciliary dyskinesia with normal ultrastructure and hyperkinetic cilia. PLoS One 8: e72299. doi: 10.1371/journal.pone.0072299
  30. 30. Austin-Tse C, Halbritter J, Zariwala MA, Gilberti RM, Gee HY, et al. (2013) Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia. Am J Hum Genet 93: 672–86. doi: 10.1016/j.ajhg.2013.08.015
  31. 31. Knowles MR, Ostrowski LE, Loges NT, Hurd T, Leigh MW, et al. (2013) Mutations in SPAG1 cause primary ciliary dyskinesia associated with defective outer and inner dynein arms. Am J Hum Genet 93: 711–20. doi: 10.1016/j.ajhg.2013.07.025
  32. 32. Zariwala MA, Gee HY, Kurkowiak M, Al-Mutairi DA, Leigh MW, et al. (2013) ZMYND10 is mutated in primary ciliary dyskinesia and interacts with LRRC6. Am J Hum Genet 9: 336–45. doi: 10.1016/j.ajhg.2013.06.007
  33. 33. Kott E, Legendre M, Copin B, Papon JF, Dastot-Le Moal F, et al. (2013) Loss-of-function mutations in RSPH1 cause primary ciliary dyskinesia with central-complex and radial-spoke defects. Am J Hum Genet 93: 561–70. doi: 10.1016/j.ajhg.2013.07.013
  34. 34. Onoufriadis A, Shoemark A, Munye MM, James CT, Schmidts M, et al. (2014) Combined exome and whole-genome sequencing identifies mutations in ARMC4 as a cause of primary ciliary dyskinesia with defects in the outer dynein arm. J Med Genet 51: 61–7. doi: 10.1136/jmedgenet-2013-101938
  35. 35. Tarkar A, Loges NT, Slagle CE, Francis R, Dougherty GW, et al. (2013) DYX1C1 is required for axonemal dynein assembly and ciliary motility. Nat Genet 45: 995–1003. doi: 10.1038/ng.2707
  36. 36. Geremek M, Bruinenberg M, Ziętkiewicz E, Pogorzelski A, Witt M, et al. (2011) Gene expression studies in cells from primary ciliary dyskinesia patients identify 208 potential ciliary genes. Hum Genet 129: 283–93. doi: 10.1007/s00439-010-0922-4
  37. 37. Inglis PN, Boroevich KA, Leroux MR (2006) Piecing together a ciliome. Trends Genet 22: 491–500. doi: 10.1016/j.tig.2006.07.006
  38. 38. Huang da W, Sherman BT, Tan Q, Collins JR, Alvord WG, et al. (2007) The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8: R183. doi: 10.1186/gb-2007-8-9-r183
  39. 39. Pazour GJ, Agrin N, Walker BL, Witman GB (2005) Identification of predicted human outer dynein arm genes: candidates for primary ciliary dyskinesia genes. J Med Genet 43: 62–73. doi: 10.1136/jmg.2005.033001
  40. 40. Whitlock MC (2005) Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. J Evol Biol 18: 1368–73. doi: 10.1111/j.1420-9101.2005.00917.x
  41. 41. Hom EF, Witman GB, Harris EH, Dutcher SK, Kamiya R, et al. (2011) A Unified Taxonomy for Ciliary Dyneins. Cytoskeleton (Hoboken) 68: 555–565. doi: 10.1002/cm.20533
  42. 42. Shi L, Jones WD, Jensen R, Shi L, Jones WD, et al. (2008) The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies. BMC Bioinfo 9: S10. doi: 10.1186/1471-2105-9-s9-s10
  43. 43. Fliegauf M, Olbrich H, Horvath J, Wildhaber JH, Zariwala MA, et al. (2005) Mislocalization of DNAH5 and DNAH9 in respiratory cells from patients with primary ciliary dyskinesia. Am J Respir Crit Care Med 171: 1343–9. doi: 10.1164/rccm.200411-1583oc
  44. 44. Thomas J, Morlé L, Soulavie F, Laurençon A, Sagnol S, et al. (2010) Transcriptional control of genes involved in ciliogenesis: a first step in making cilia. Biol Cell 102: 499–513. doi: 10.1042/bc20100035